Search Results 241-250 of 16606 for Proto-oncogene
Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.
For example, some studies focus on identifying genetic changes that might affect cancer risk. Other studies address how differences in DNA influence patients' ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
ROCHESTER, Minn. — A Mayo Clinic study finds that a shortened, less intense course of radiation and chemotherapy after minimally invasive surgery for ...
This study aims to identify cases of FGF23-mediated oncogenic osteoomalacia in which the underlying phosphaturic mesenchymal has not been found and perform ...
... oncogenic states in conditions such as aging and cancer. A clear understanding of stem cell differentiation processes and the biology of cancer risk ...
Learn about the experts and services, including awake brain surgery, available for the diagnosis and treatment of brain and central nervous system tumors.
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.